Financial & Investment Management Group’s Array Biopharma Inc ARRY Stock Holding History

Financial & Investment Management Group’s Portfolio ARRY Stock Details ARRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	$4.21M	Sell	295,610 -38,994	-12%	-$591K	1.54%	21
2018 Q3	$5.09M	Buy	334,604 +112,551	+51%	+$1.72M	1.67%	21
2018 Q2	$3.73M	Buy	222,053 +87,302	+65%	+$1.39M	1.18%	35
2018 Q1	$2.2M	Sell	134,751 -86,055	-39%	-$1.38M	0.71%	46
2017 Q4	$2.83M	Sell	220,806 -5,450	-2%	-$62K	0.98%	34
2017 Q3	$2.78M	Buy	+226,256	New	+$2.1M	0.92%	32

Other funds holding ARRY

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Financial & Investment Management Group's ARRY Position: Q4 2018 in Review

Financial & Investment Management Group reduced its Array Biopharma Inc (ARRY) stake by 12% in Q4 2018, selling an estimated $591K and leaving 295,610 shares worth $4.21M. The position accounts for 1.54% of the portfolio, ranked #21.

Financial & Investment Management Group first reported a position in ARRY in Q3 2017 and has held it in 6 quarters since. The position peaked at $5.09M in Q3 2018. 236 funds tracked by Wall St. Rank hold ARRY as of Q4 2018.

Financial & Investment Management Group held 295,610 shares of Array Biopharma Inc worth $4.21M as of Q4 2018.
Financial & Investment Management Group sold 38,994 Array Biopharma Inc shares in Q4 2018, an estimated $591K.
Array Biopharma Inc made up 1.54% of Financial & Investment Management Group's portfolio in Q4 2018, its #21 holding.
Financial & Investment Management Group first reported a position in Array Biopharma Inc in Q3 2017 and has held it in 6 quarters since.
Financial & Investment Management Group's Array Biopharma Inc position peaked at $5.09M in Q3 2018.
236 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q4 2018.

Based on Financial & Investment Management Group's 13F filing for Q4 2018, filed 30 Jan 2019.